About Virustatic
Virustatic is a company based in Stockport (United Kingdom) founded in 2009. The company has 1 employees. Virustatic offers products and services including Viruferrin, Viral Filtration Technologies, Period and Cycle Care Products, Sustainable Antimicrobial Textiles, and Biofilm Prevention Solutions. Virustatic operates in a competitive market with competitors including G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.
- Headquarter Stockport, United Kingdom
- Employees 1
- SectorsHealthcare
- Website virustatic.com
- Social LinkedIn X Facebook
- Legal Name Virustatic Limited
- Date of Incorporation 25 Sep, 2009
- Jurisdiction MACCLESFIELD, CHESHIRE, UNITED KINGDOM
- Latest Funding Round$204.02K (USD), Grant
Oct 2021
- Investors
- Employee Count1
Products & Services of Virustatic
Virustatic offers a comprehensive portfolio of products and services, including Viruferrin, Viral Filtration Technologies, Period and Cycle Care Products, Sustainable Antimicrobial Textiles, and Biofilm Prevention Solutions.
Protein-based textile treatment for antiviral and antibacterial protection.
Innovative solutions for viral prevention in health applications.
Sustainable items for personal hygiene and microbial resistance.
Eco-friendly fabrics with built-in antimicrobial properties.
Technologies to inhibit surface biofilm formation in various settings.
Funding Insights of Virustatic
- Total Rounds 2
- Last Round Grant — $204,023
- Investors Count 2
All 2 funding rounds of Virustatic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2021 | $204,023 | Grant | – | – | |
| Sep 2016 | – | Seed | – | – |
2 investors in total: 2 institutional.
Investors in Virustatic
Virustatic has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Business of Fashion, Textiles and Technology (BFTT) and Catapult Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment solutions are provided by Catapult Ventures for growth. | – | catapult-ventures.com | Leicester, United Kingdom | |
Sustainable innovation is fostered within fashion and textile industries. | – | bftt.org.uk | London, United Kingdom |
Investor details for Virustatic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Virustatic
3 dated milestones of Virustatic across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Virustatic is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $204K.
Competitors of Virustatic
Virustatic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as G-Con Manufacturing, Comecer, NuAire, Noroit and Landauer, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gconbio.com | 2009 | College Station, United States | $13M | 43 | Builds and installs prefabricated, autonomous cleanrooms | |
| comecer.com | 1974 | Castel Bolognese, Italy | $10.57M | 4 | Protective equipment and containment systems for nuclear medicine, nuclear power plants and aseptic manufacturing | |
| nuaire.com | 1971 | Plymouth, United Kingdom | – | 265 | Laboratory safety equipment is manufactured for research and industrial use. | |
| noroitlabo.com | 2006 | Bouaye, France | $496,282 | – | Developer of protective equipment against biological risks for research, pharma and hospital sectors | |
| landauer.com | 1954 | Glenwood, United States | – | – | Radiation monitoring and protection | |
| biosci-intl.com | 1996 | Rockville, United States | – | 10 | Manufactures air sampling equipment to detect contamination in food, pharmaceutical, and hospital environments. | |
| isolationsciences.com | 2006 | Williamsville, United States | $150,000 | – | Fume hood retrofit kits with movable access ports are manufactured. | |
| vitrologybiotech.com | 2007 | Glasgow, United Kingdom | – | – | Biosafety testing for biologics is conducted to ensure compliance. | |
| genetoo.com | 2017 | Rehoboth Beach, United States | – | – | Aseptic surfaces for medical implants are created via laser technology. |
Detailed competitors of Virustatic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Virustatic
10 companies that operate in the same segment as Virustatic (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Virustatic
Virustatic was founded in 2009 and raised its 1st funding round 7 years after it was founded.
Virustatic is headquartered in Stockport, United Kingdom. It is registered at Stockport, Greater Manchester, United Kingdom.
Virustatic has 1 employees.
Virtustatic has designed a new anti-viral technology which acts as a filter to inhibit exhalation and inhalation of viruses and other pathogens. The company claims that 99.9 of airborne flu viruses were captured by their patented design at University of Manchester which established their proof of concept.
Virustatic's top competitors include G-Con Manufacturing, Comecer and NuAire.
Virustatic offers Viruferrin, Viral Filtration Technologies, Period and Cycle Care Products, Sustainable Antimicrobial Textiles, and Biofilm Prevention Solutions.
Virustatic has 2 investors. Key investors include Business of Fashion, Textiles and Technology (BFTT), and Catapult Ventures.
Virustatic operates through Virustatic Limited.